# PSMA-PET Guided Radiotherapy

> **NCT03525288** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 130 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** PSMA -PET/CT simulation
- **RADIATION:** Standard-care simulation

## Key facts

- **NCT ID:** NCT03525288
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-05-15
- **Primary completion:** 2026-05-30
- **Final completion:** 2027-05-30
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2025-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03525288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03525288, "PSMA-PET Guided Radiotherapy". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03525288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*